UBE3A and Angelman syndrome: In 1997, it was shown that genetic alterations of the UBE3A gene, resulting in loss of E6AP expression or in the expression of E6AP variants with compromised E3 activity, are the cause of the Angelman syndrome (AS), a neurodevelopmental disorder17–20.